Monash IVF Group Executive and Leadership Team

Michael Knaap, the Chief Executive Officer & Managing Director at Monash IVF Group, directs the overarching corporate strategy and long-term growth initiatives. Overseeing the expansion of assisted reproductive technologies across Oceania, the Chief Executive Officer & Managing Director ensures alignment between clinical excellence and commercial performance. This leadership role involves constant engagement with the Board to refine diagnostic health service delivery models. By optimizing operational frameworks, Michael Knaap drives the organization toward sustained market leadership in the fertility sector. The Chief Executive Officer & Managing Director manages complex stakeholder relationships to maintain the reputation of the company as a pioneer in reproductive medicine. Through rigorous oversight of regional performance, Knaap secures the financial health of the enterprise. This executive focus guarantees that the company remains at the forefront of medical innovation while delivering consistent value to patients and shareholders throughout the diverse Australian healthcare landscape.

Birol Akdogan, the Interim Chief Financial Officer at Monash IVF Group, directs the financial planning, reporting, and capital allocation strategies. Overseeing the fiscal health of the organization, the Interim Chief Financial Officer ensures that resources support the expansion of fertility treatment services across Oceania. This leadership role involves managing budgetary discipline and financial risk to sustain the long-term viability of the company. By analyzing revenue streams from diagnostic health services, Birol Akdogan drives informed decision-making for the executive team. The Interim Chief Financial Officer coordinates with the Board to provide transparent financial insights and strategic guidance. Through the management of financial controls and investment analysis, Akdogan supports the growth objectives of the enterprise. This executive focus ensures that the company maintains a strong balance sheet, enabling continued investment in pioneering reproductive technologies and the delivery of high-quality patient care.

Rebecca Redden, the Chief Operating Officer at Monash IVF Group, executes the daily operational strategy across the network of fertility clinics. Overseeing the delivery of assisted reproductive technologies, the Chief Operating Officer ensures that every facility adheres to the highest standards of clinical care and efficiency. This leadership role involves managing the logistics of diagnostic health services to maintain seamless patient experiences throughout Oceania. By optimizing resource allocation and staff workflows, Rebecca Redden drives operational excellence and service consistency. The Chief Operating Officer collaborates with medical directors to implement new treatment protocols that enhance success rates. Through the rigorous monitoring of clinic performance metrics, Redden ensures that the company meets its ambitious growth targets. This executive focus guarantees that the organization maintains its status as a leader in the fertility sector by providing reliable, high-quality care in every clinical setting.

Thierry Panthier, the Chief Information Officer at Monash IVF Group, architects the digital infrastructure supporting advanced reproductive technologies. Overseeing the integration of diagnostic data systems, the Chief Information Officer ensures secure and efficient information flow across all clinical locations. This leadership role involves modernizing the technological stack to enhance patient outcomes and streamline fertility treatment workflows. By implementing robust cybersecurity protocols, Thierry Panthier protects sensitive health information while enabling seamless digital access for medical practitioners. The Chief Information Officer collaborates with clinical teams to deploy innovative software solutions that improve diagnostic accuracy. Through the management of enterprise-wide IT initiatives, Panthier drives operational efficiency across the Oceania network. This executive focus ensures that the company maintains a competitive edge through superior data management and digital connectivity, ultimately supporting the mission of providing world-class fertility services through reliable and scalable technological platforms.

Fiona Allen, the Chief Marketing Officer at Monash IVF Group, directs the brand strategy and patient acquisition efforts for fertility treatment services. Overseeing the communication of complex reproductive health solutions, the Chief Marketing Officer ensures that the market presence reflects the pioneering history of the organization. This leadership role involves crafting targeted campaigns that educate prospective patients on available in vitro fertilization options. By analyzing consumer trends across Oceania, Fiona Allen optimizes the outreach strategy to increase service accessibility. The Chief Marketing Officer coordinates with clinical leadership to translate medical advancements into clear, accessible messaging for the public. Through the management of brand reputation and digital engagement, Allen drives growth in patient volume. This executive focus ensures that the company maintains a strong connection with the community, effectively positioning the organization as the premier choice for comprehensive fertility care and diagnostic health services.

Jonathan Beever, the Interim Chief Information Officer at Monash IVF Group, manages the stability and evolution of the internal technology environment. Overseeing the maintenance of critical diagnostic systems, the Interim Chief Information Officer ensures that clinical teams possess the tools required for precise fertility treatments. This leadership role involves addressing immediate technical challenges while planning for long-term digital transformation across the Oceania network. By streamlining internal communication platforms, Jonathan Beever drives improved collaboration between administrative and medical departments. The Interim Chief Information Officer works closely with the IT staff to ensure system uptime and data integrity for all reproductive health records. Through the oversight of infrastructure upgrades, Beever supports the operational continuity of the company. This executive focus ensures that the organization remains resilient and technologically capable, providing a stable foundation for the delivery of advanced fertility solutions to patients.

Marnie Kalinski, the Interim Chief People Officer at Monash IVF Group, directs the human capital strategy and organizational culture initiatives. Overseeing the recruitment and retention of specialized medical and administrative talent, the Interim Chief People Officer ensures that the workforce remains aligned with the mission of providing exceptional fertility care. This leadership role involves developing training programs that support the professional growth of clinical staff across Oceania. By fostering an inclusive and high-performance environment, Marnie Kalinski drives employee engagement and operational productivity. The Interim Chief People Officer collaborates with department heads to address workforce needs and maintain high standards of patient service. Through the management of talent development and organizational design, Kalinski supports the overall growth of the company. This executive focus ensures that the organization attracts and retains the best professionals in the fertility sector, ultimately enhancing the quality of care provided to patients.